We at Cello Health sincerely hope this finds you, your family and friends safe and healthy. We also want to express our sincere gratitude to essential workers and to all those on the front line dealing with this crisis.
With the advent of the recent COVID crisis, our overriding objective has been to ensure the safety of our employees.
The entire employee base of the Group has been working remotely for a number of weeks now, delivering largely uninterrupted services consistent with our commitment to clients to ensure the continuation of business. Our people are showing great resilience, creativity and ingenuity in partnering with clients to find new ways to provide continuity of services. We are proud of our agility and ability to deploy both new and existing digital technologies within the Group to replace all live contact and enable virtual workshops, meetings, and interviews to be carried out to great effect.
We recognise that these are very challenging times for our people and have ensured that all leaders and managers in our business are sensitive to the pressures this crisis can create for anyone working from home, many of whom are now simultaneously handling a different household dynamic with children and possibly essential workers to care for. Health and well-being is top of mind in relation to ensuring we look after our people whilst delivering services to our clients during this time of great uncertainty. In this context, we have implemented an augmented ‘modus operandi’ in relation to how we manage, communicate, and provide support services across the Cello Health family during this stressful time.
In our work as expert providers of marketing services we’re proud to be supporting the Scottish Government in the creation of a series of compelling public health campaigns to drive social distancing and self- isolation as well as heightened community spirit and protecting the most vulnerable in our society. We are also working with the European Federation of Pharmaceutical Industries (EFPIA) to support their activities as they focus on providing world-leading science, people and resources to tackle the Covid-19 outbreak.
In addition, our regulatory consultancy practice in the US is preparing a number of submissions to the FDA, known as Emergency Use Authorisations, for the repurposing of facilities or products in the pandemic. Examples include approval of conversion of a manufacturing facility to make masks and hospital gowns. Globally, we are also currently working to quickly alter programs that heighten our client’s ability to continue to provide access to crucial new treatments and support in areas such as oncology and MS.
Our business continuity framework prepared us well for the changes necessitated over the past several weeks; our business continuity team continues to carefully monitor the development of the Covid-19 outbreak and we will continue to adjust as need be to meet our commitments to employee well-being and client business continuity. In addition, we continue to monitor all advice and guidance issued by the Department of Health and Social Care, Public Health England and World Health Organisation.
If you have any immediate questions or require any further information, please contact your Client Account contact in the first instance
Join us at the Pharmaceutical Management Science Association Virtual Meeting December 3-4, 2020 and visit our poster on Analogue Intelligence: Growing Both Players in a Duopoly Market, a case study from our growing practice in identifying and extracting learnings from analogues facing similar strategic challenges.
The acquisition of Cello Health provides the foundation for a new enterprise to enable healthcare and biopharmaceutical clients to maximize the value of their products.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us